@article{27795, author = {Chowdhry S and Shukla A and D'Souza P and Dhali T and Jaiswal P}, title = {Treatment of severe refractory erythema nodosum leprosum with tumor necrosis factor inhibitor Etanercept.}, abstract = {
Erythema nodosum leprosum (ENL) is a common complication of lepromatous leprosy. Some patients unresponsive to conventional, first-line therapeutics develop recurrent, recalcitrant ENL. Here, we report a case of severe refractory ENL that was successfully treated with Etanercept. Biologics may be considered as therapeutic alternatives in management of severe, recalcitrant ENL.
}, year = {2016}, journal = {International journal of mycobacteriology}, volume = {5}, pages = {223-5}, issn = {2212-554X}, url = {http://www.sciencedirect.com/science/article/pii/S2212553116000212}, doi = {10.1016/j.ijmyco.2016.02.002}, language = {eng}, }